Volume | 653,303 |
|
|||||
News | - | ||||||
Day High | 0.83 | Low High |
|||||
Day Low | 0.6551 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.7189 | 0.6551 | 0.83 | 0.70 | 0.8299 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,428 | 653,303 | $ 0.7361592 | $ 480,935 | - | 0.50 - 6.85 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:51:33 | formt | 1,100 | $ 0.6898 | USD |
Phio Pharmaceuticals Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.71M | 2.44M | - | 0 | -10.83M | -4.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Phio Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.649 | 1.05 | 0.604849 | 0.8261417 | 1,494,228 | 0.0408 | 6.29% |
1 Month | 0.76 | 1.05 | 0.604849 | 0.8102577 | 444,121 | -0.0702 | -9.24% |
3 Months | 0.58 | 1.15 | 0.5459 | 0.8444616 | 454,558 | 0.1098 | 18.93% |
6 Months | 1.42 | 2.09 | 0.50 | 1.17 | 509,820 | -0.7302 | -51.42% |
1 Year | 3.73 | 6.85 | 0.50 | 2.38 | 625,248 | -3.04 | -81.51% |
3 Years | 27.48 | 34.20 | 0.50 | 15.67 | 715,830 | -26.79 | -97.49% |
5 Years | 5.94 | 130.20 | 0.50 | 19.06 | 728,592 | -5.25 | -88.39% |
Phio Pharmaceuticals Description
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |